AbCellera Biologics Inc. (NASDAQ:ABCL) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month […]
More Stories
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...
Thiel Macro LLC Invests $33.16 Million in NVIDIA Co. (NASDAQ:NVDA)
Thiel Macro LLC acquired a new position in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according to...
Thiel Macro LLC Invests $33.16 Million in NVIDIA Co. (NASDAQ:NVDA)
Thiel Macro LLC acquired a new position in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according to...
Thiel Macro LLC Invests $33.16 Million in NVIDIA Co. (NASDAQ:NVDA)
Thiel Macro LLC acquired a new position in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according to...